SPP-ARV-825

N/A

Report date: 2023/03/02 16:29:20
NME

Base Information

Drug NameSPP-ARV-825
Drug Alias NameSPP-ARV-825
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionBromodomain-containing protein 4 degraders
TargetsBromodomain-containing protein 4
Therapy Area/IndicationsGlioma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesWest China Hospital Of Sichuan University
China Registration ClassN/A

Develop Information

Active CompaniesWest China Hospital Of Sichuan University
Inactive CompaniesN/A
Active IndicationsGlioma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A